Why the study?
Does combined proton beam therapy and local hyperthermia provide local control for large inoperable malignant fibrous histiocytoma?
Does combined proton beam therapy and local hyperthermia provide local control for large inoperable malignant fibrous histiocytoma?
Answers are grounded in this paper and cite their sources.
Combined proton beam therapy and local hyperthermia may be an effective limb-preserving treatment option for large inoperable malignant fibrous histiocytoma.
PURPOSE: Malignant fibrous histiocytoma (MFH) is one of the most common soft tissue sarcomas. The standard treatment is adequate surgical resection; in addition, radiation therapy plays a major role in perioperative treatment in most cases. Herein, we report the case of a patient with a large MFH who was successfully treated with combined proton beam therapy (PBT) and local hyperthermia (LH). CASE PRESENTATION: A 60-year-old man presented with a 6×4-cm mass on his left thigh. Histopathology and immunohistochemistry indicated MFH, and he refused limb amputation. He received treatment with PBT at a dose at 72 GyE in 18 fractions. To cover the entire large target lesion, we used a patch-field protocol. He also concurrently received 7 courses of LH. The combination therapy achieved long-term local control without severe acute or late toxicity during the 7-year follow-up period. CONCLUSIONS: This case suggests that the combination of PBT and LH may be an option as a limb-preserving treatment for large inoperable MFH in the extremities.
No takes yet. Share an insight, caveat, or question.
Iizumi et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: